Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002

Frank G. Bottone, William T. Barry

Open source

DOI: 10.1185/03007990902953286
Published: 2009-05-14
Container: Current Medical Research and Opinion
Publisher: Informa Healthcare
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1185/03007990902953286,
  title = {Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002},
  author = {Frank G. Bottone and William T. Barry},
  year = {2009},
  journal = {Current Medical Research and Opinion},
  doi = {10.1185/03007990902953286},
  url = {https://doi.org/10.1185/03007990902953286}
}

RIS

TY  - JOUR
TI  - Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002
AU  - Frank G. Bottone
AU  - William T. Barry
PY  - 2009
JO  - Current Medical Research and Opinion
DO  - 10.1185/03007990902953286
UR  - https://doi.org/10.1185/03007990902953286
ER  -

APA

Bottone, F. G., & Barry, W. T. (2009). Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002. Current Medical Research and Opinion. https://doi.org/10.1185/03007990902953286

Source records

crossref · retrieved 2026-09-25T06:25:19.698Z